Yamada Tadataka 4
4 · Phathom Pharmaceuticals, Inc. · Filed May 24, 2021
Insider Transaction Report
Form 4
Yamada Tadataka
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2021-05-21+12,500→ 12,500 totalExercise: $35.49Exp: 2031-05-20→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The option was granted pursuant to the Registrant's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Registrant's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.